Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Turns To Insider Ian Read To Lead Into Post-Lipitor Era

This article was originally published in The Tan Sheet

Executive Summary

Pfizer's election of Ian Read as president, CEO and director of the company sets the stage for a management transition at the firm, which has underperformed its peers on several measures in recent years.

You may also be interested in...



Pfizer CEO Read Will Pass The Torch To Bourla In 2019

Chief Operating Officer Albert Bourla will succeed Ian Read as CEO of Pfizer, taking over the top spot at a steady point in the big pharma's evolution. Bourla's near-term challenges will be navigating the loss of Lyrica and the changing US health care dynamics.

People In Brief

Read takes helm of Pfizer’s board; Devereux succeeds Rose as Schwabe CEO; USANA shakes up marketing team; Schiff board adds eBay vet; more People In Brief

People In Brief

Read takes helm of Pfizer’s board; Devereux succeeds Rose as Schwabe CEO; USANA shakes up marketing team; Schiff board adds eBay vet; more People In Brief

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104744

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel